Pesquisas alternativas:
development type » development types (Expandir a Pesquisa), development time (Expandir a Pesquisa), development three (Expandir a Pesquisa)
developing open » developing novel (Expandir a Pesquisa), developing optic (Expandir a Pesquisa), developing spinal (Expandir a Pesquisa)
dose develop » bse develop (Expandir a Pesquisa), mouse develops (Expandir a Pesquisa), noise develops (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
drug de » drug dna (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 62 para a pesquisa '(( drug de ((development type) or (developing open)) ) or ( drug dose develop type ))', tempo de pesquisa: 2.19seg Refinar resultados
Dose‐Finding Studies Among Orphan Drugs Approved in the EU: A Retrospective Analysis
Metformin causes a futile intestinal–hepatic cycle which increases energy expenditure and slows down development of a type 2 diabetes-like state

Previous spatial learning is required for the development of place preference in rats following chronic administration of and withdrawal from morphine
Identification and Assessment of Adherence-Enhancing Interventions in Studies Assessing Medication Adherence Through Electronically Compiled Drug Dosing Histories: A Systematic Literature Review and Meta-Analysis

Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus
Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial

Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
The Costs and Cost-Effectiveness of Mass Treatment for Intestinal Nematode Worm Infections Using Different Treatment Thresholds

7th drug hypersensitivity meeting: part one
In vivo chemotherapeutic insight of a novel isocoumarin (3-hexyl-5,7-dimethoxy-isochromen-1-one): Genotoxicity, cell death induction, leukometry and phagocytic evaluation

Delirium risk screening and haloperidol prophylaxis program in hip fracture patients is a helpful tool in identifying high-risk patients, but does not reduce the incidence of delirium
MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR–TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan Regimen

Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
Costs and benefits of bevacizumab vial sharing for the treatment of retinal diseases

A multicenter open-label treatment protocol (HGT-GCB-058) of velaglucerase alfa enzyme replacement therapy in patients with Gaucher disease type 1: safety and tolerability
Herpes simplex virus: isolation, cytopathological characterization and antiviral sensitivity()

Novel SGLT2 inhibitor: first‐in‐man studies of antisense compound is associated with unexpected renal effects
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system
STatistically Assigned Response Criteria in Solid Tumors (STARCIST)

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa